Discontinuation report NOVOLIN GE 40/60 PENFILL

Last updated on 2022-09-07 History
Report ID 168714
Drug Identification Number 02024314
Brand name NOVOLIN GE 40/60 PENFILL
Common or Proper name NOVOLIN GE 40/60 PENFILL
Company Name NOVO NORDISK CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN ISOPHANE HUMAN BIOSYNTHETIC INSULIN INJECTION HUMAN BIOSYNTHETIC
Strength(s) 60UNIT 40UNIT
Dosage form(s) SUSPENSION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size EA
ATC code A10AD
ATC description INSULINS AND ANALOGUES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2023-03-31
Actual discontinuation date
Remaining supply date 2023-03-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Supply to wholesalers estimated to last until March 2023
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-09-07 English Compare
v2 2022-09-07 French Compare
v3 2022-09-07 French Compare

Showing 1 to 3 of 3